Expert Interview

This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Discussing data from the Phase 4 Phase 4 IMMpulse study regarding AbbVie's SKYRIZI (risankizumab) for treatment of moderate plaque psoriasis

Ticker(s): ABBV

Who's the expert?

Institution: Conway Medical

Manages about 15 to 20 patients with Prurigo Nodularis and 45 patients with non-segmental vitiligo
familiar with Haduvio and it's Phase 2b/3 PRISM trial
Published multiple papers in dermatology

Interview Goal

This interview will focus on the recent data published in the BJD regarding the Phase 4 IMMpulse study on the comparison of risankizumab and apremilast for treatment of moderate plaque psoriasis.

Do you want answers to these questions?

Yes! Sign me up for FREE
so I can learn more Yes.
LOGIN!

Click Here to Access
This Project

Slingshot Insights Explained

JOIN FOR FREE TODAY

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

Click Here to Access
This Project

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.